Location: Home
  • search
  • go
  • Relate News
  • 10/29/2023Coherus and Junshi Won FDA Approval of LOQTORZI (toripalimab-tpzi) for...
  • 10/29/2023Intas and Henlius Enter into Exclusive License Deal for Serplulimab in...
  • 10/29/20232023 Outlook for China's NRDL (Simon Kucher)
  • 10/25/2023Snapshot of BMI System Financial Performance in 3Qs/2023
  • 10/25/2023NMPA Issues the Guide to On-Site Inspection of Contract Manufacture by...
  • 10/25/2023Kyowa Kirin Expands Production Capacity in China
  • 10/24/2023NPC Reviews Draft Amendmets of the Infectious Disease Prevention and C...
  • 10/24/2023LianBio Enters into Agreement with BMS for Mavacamten in China and Oth...
  • 10/24/2023Medytox to Enter China's Botulinum Toxin Market with Newlux
  • 10/24/2023MIIT: Chinese Pharma Industry Up 9.3% in 14th FYP Period
  • 10/24/2023CDE Solicits Comments on the Technical Guidelines for Clinical R&D of ...
  • 10/23/2023Belief BioMed and Takeda China Announce Exclusive Commercial Deal in t...
  • 10/23/2023China Issues Guideline to Facilitate Childcare Services
  • 10/23/2023NMPA Issues Announcement on Strengthening the Regulation of Contract M...
  • 10/23/2023Merck Drops Co-development of Two ADCs from Sichuan Kelun
  • 10/23/2023Sino Biological to Buy Canada's SignalChem Biotech for Up to $48M
  • 10/23/2023China Establishes National Standardized Pain Treatment Center
  • 10/19/2023NHSA: Prevailing Generic Drugs in VBP Equivalent to Originator Drugs i...
  • 10/19/2023CDE Issues Two Technical Guidelines for Liposome Drugs
  • 10/19/2023Recent Executive Moves
  • 10/18/2023MOF Drafts New Policy to Improve Internal Control of Public Hospitals
  • 10/18/2023JPO Officially Announces Initiation and Info Submission Arrangements o...
  • 10/18/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of New...
  • 10/17/2023Elevar and Hengrui Announce Global License Deal for PD-1 Inhibitor Cam...
  • 10/17/2023China's BMI System Saw Its Income Up 9.3% in the First Eight Months 
  • 10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/15/2023The SparX Group Enters into a Collaboration with Arovella Therapeutics...
  • 10/15/2023EpimAb and Almirall Announce Bispecific Antibody License Agreement
  • Page:39/356 Total number of articles:10656: [First][<<] [37] [38] [39] [40] [41] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group